Pharmacokinetic/Pharmacodynamic Modeling of the Antiretroviral Activity of the CCR5 Antagonist Vicriviroc in Treatment Experienced HIV-Infected Subjects (ACTG Protocol 5211)

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0b013e3181c9caac
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Inefficient Entry of Vicriviroc-Resistant HIV-1 via the Inhibitor-Ccr5 Complex at Low Cell Surface CCR5 Densities

Virology
Virology
2009English

Incidence of Non-Aids-Defining Cancer in Antiretroviral Treatment-Naïve Subjects After Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis

Oncology
MedicineCancer ResearchOncology
2011English

Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Depot Testosterone Cypionate in Healthy Male Subjects

English

Effectiveness of Enfuvirtide in a Cohort of Highly Antiretroviral-Experienced HIV-1-infected Patients in Mexico

AIDS Research and Therapy
VirologyMolecular MedicinePharmacology
2014English

Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2010English

Early Markers of Tubular Dysfunction in Antiretroviral-Experienced HIV-Infected Patients Treated With Tenofovir Versus Abacavir

AIDS Patient Care and STDs
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2012English

Antiretroviral Treatment Regimen Outcomes Among HIV-Infected Prisoners

HIV Clinical Trials
2007English

Population Pharmacokinetic-Pharmacodynamic Modeling of Captopril in Healthy Volunteers

Journal of Korean Society for Clinical Pharmacology and Therapeutics
2001English

British HIV Association (BHIVA) Guidelines for the Treatment of HIV-infected Adults With Antiretroviral Therapy

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy